Teva is encouraging people to get outside with its latest collection and brand anthem. According to the Deckers Brands-owned footwear brand, it has launched “For Playground Earth,” a new anthem and ...
Teva Gains Biosimilar Momentum with U.S. FDA Approval of PONLIMSI™ (denosumab-adet) and Dual Filing Acceptance for Biosimilar Candidate to Xolair® (omalizumab) ...
Parade on MSN
Teva’s traveler-approved strappy sandals feel like 'walking on clouds,' and they’re now $27 at Amazon
“They offer much more support than your typical flip-flop.” ...
Strong biosimilars performance with growth from existing and newly launched products. Expecting two new launches in the second half of 2025. On track to double biosimilar revenues from 2024 to 2027.
After offloading a big chunk of their Japanese generics joint venture in 2020, Teva and Takeda have decided to divest the business in its entirety so they can each focus on their innovative medicines.
Sport sandal footwear brand Teva last week introduced a new brand anthem, dubbed “For Playground Earth,” highlighting its commitment to crafting footwear for trail, water and camp and to encourage ...
On Wednesday, Teva Pharmaceutical Industries Ltd (NYSE:TEVA) reported second-quarter 2024 sales of $4.16 billion, beating the consensus of $4.06 billion. Revenues increased 7% year-over-year and 11% ...
Teva Pharmaceuticals swung to a profit in the fourth quarter, as strong sales from its name-brand products offset underwhelming results from generics. The Israeli pharmaceutical company on Wednesday ...
Teva Pharmaceuticals recalled 13 lots of fentanyl buccal tablets, a Type II substance, because of omitted safety updates on its medication guide, the FDA said April 28. The agency said the main ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results